Income Statement
RALLYBIO CORP
RLYB
Performance Overview
Click any row in the table to add it to this chart
in millions USD
| Metric | Dec 31, 2025 2025 FY | Dec 31, 2024 2024 FY | Dec 31, 2023 2023 FY | Dec 31, 2022 2022 FY | Dec 31, 2021 2021 FY |
|---|---|---|---|---|---|
|
Revenue
|
0.86 | 0.64 | - | - | - |
|
Cost of Revenue
|
- | - | - | - | - |
|
Gross Profit
|
0.86 | 0.64 | - | - | - |
|
Operating Expenses
|
33.92 | 61.13 | 78.93 | 67.88 | 45.65 |
|
Research & Development
|
19.60 | 41.51 | 53.54 | 40.69 | 26.91 |
|
Selling, General & Administrative
|
14.33 | 19.63 | 25.39 | 27.20 | 18.74 |
|
Other Operating Expenses
|
- | - | - | - | - |
|
Operating Income
|
-33.06 | -60.50 | -78.93 | -67.88 | -45.65 |
|
Non-Operating Income
|
24.96 | 4.96 | 6.41 | 2.31 | 0.14 |
|
Interest Income
|
- | - | - | - | - |
|
Interest Expense
|
- | - | - | 0.00 | 0.01 |
|
Other Non-Op Income / Expense
|
22.77 | 2.20 | 0.26 | 1.10 | 1.50 |
|
Income Before Tax
|
-8.10 | -55.54 | -72.52 | -65.58 | -45.51 |
|
Income Tax Expense
|
0.87 | 2.24 | 2.04 | 1.08 | 1.51 |
|
Non-Controlling Interest
|
- | - | - | - | - |
|
Net Income
|
-8.98 | -57.78 | -74.56 | -66.65 | -47.01 |
Supplemental
Per share data, derived & other items — not part of the income statement
in millions USD unless noted
| Metric | Dec 31, 2025 2025 FY | Dec 31, 2024 2024 FY | Dec 31, 2023 2023 FY | Dec 31, 2022 2022 FY | Dec 31, 2021 2021 FY |
|---|---|---|---|---|---|
|
Depreciation & Amortization
|
- | - | - | - | - |
|
EBITDA
|
-32.97 | -60.37 | -78.78 | -67.72 | -45.54 |
|
Earnings Per Share (Basic)
|
-1.59 | -1.33 | -1.84 | -2.09 | - |
|
Diluted EPS
|
-1.59 | -1.33 | -1.84 | -2.09 | - |
|
Weighted Average Shares
|
5.63 | 43.54 | 40.45 | 31.82 | - |
|
Diluted Weighted Avg Shares
|
5.63 | 43.54 | 40.45 | 31.82 | - |
|
Comprehensive Income
|
-9.03 | -57.72 | -74.34 | -66.87 | -47.01 |